Text and Data Mining valid from 2019-06-06
Received: 20 October 2018
Accepted: 8 April 2019
First Online: 6 June 2019
Ethics approval and consent to participate
: Ethical approval was obtained from the Human Research Ethics Committees of Princess Margaret Hospital (2015030EP), Joondalup Health Campus (1501), Curtin University (HRE2018–0016) and The University of Queensland (2015000395 / 2016.01.179). All participants parents or guardians signed a consent to participate form.
: PP and UA are scientific advisors and shareholders in ResApp Health (RAP). UA is RAP’s Chief Scientist. RAP is commercialising the technology under license from the University of Queensland, where UA is employed. UA and VS are named inventors of the UQ technology. DS, JB and PD declare no competing interests. TN, JT, VS and JC are shareholders in RAP.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.